Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

AblatePal Radiofrequency Ablation System

K-Number: K223135 · 2023-06-30

Decision Date2023-06-30
Product CodeGEI
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

AblatePal Radiofrequency Ablation System is a medical device manufactured by Compal Electronics, Inc.. It received FDA 510(k) clearance on 2023-06-30 under approval number K223135. The device is classified under product code GEI. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the AblatePal Radiofrequency Ablation System?

AblatePal Radiofrequency Ablation System is a medical device that received FDA 510(k) clearance on 2023-06-30. It is manufactured by Compal Electronics, Inc.. The 510(k) number is K223135.

When was AblatePal Radiofrequency Ablation System approved by the FDA?

AblatePal Radiofrequency Ablation System received FDA 510(k) clearance on 2023-06-30, under approval number K223135.

What company makes AblatePal Radiofrequency Ablation System?

AblatePal Radiofrequency Ablation System is manufactured by Compal Electronics, Inc..

What is the FDA product code for AblatePal Radiofrequency Ablation System?

The FDA product code for AblatePal Radiofrequency Ablation System is GEI.

Related Clinical Trials

Related PubMed Literature

Other Devices by Compal Electronics, Inc.

Related Devices (Code: GEI)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.